ArticleOpen forum infectious diseases2024

Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19-related Hospitalizations and Medical Encounters Among Adults in the United States.

Hagit Kopel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.